Xtane Tablet (Exemestane 25 mg) – 30 Tablets

About this Medicine

Xtane Tablet, containing 25 mg of Exemestane, is a vital medication in the therapeutic arsenal against certain types of breast cancer. As an aromatase inhibitor, Xtane plays a crucial role in managing hormone-receptor-positive breast cancer, primarily in postmenopausal women. This condition is often fueled by estrogen, a hormone naturally produced in the body. By effectively reducing the amount of estrogen available, Xtane helps to slow down or even stop the growth of breast cancer cells that depend on this hormone for proliferation. Exemestane, the active ingredient in Xtane, works by irreversibly binding to the aromatase enzyme, which is responsible for converting androgen hormones into estrogens in various tissues, including fat and muscle. In postmenopausal women, the ovaries no longer produce significant amounts of estrogen, and this conversion becomes the primary source of estrogen in the body. By inhibiting aromatase, Xtane significantly lowers estrogen levels, thereby depriving hormone-dependent breast cancer cells of the necessary growth stimulus. This mechanism makes Xtane a targeted therapy, offering a precise approach to treatment. Patients prescribed Xtane are typically postmenopausal women diagnosed with early or advanced hormone-receptor-positive breast cancer. It may be used as an adjuvant therapy following initial treatments like surgery and/or radiation, or for advanced disease that has progressed despite prior anti-estrogen therapies. Choosing the right treatment plan involves careful consideration by your healthcare provider, taking into account your specific cancer type, stage, and overall health. Always consult with a qualified oncologist to understand how Xtane fits into your comprehensive cancer care strategy and to discuss potential benefits and considerations.